Clinical Trials Logo

Filter by:
NCT ID: NCT01773304 Completed - Obesity Clinical Trials

Acute Effects of Dairy and Meat Proteins on Bone Metabolism and Metabolic Profile

MEDA
Start date: December 2012
Phase: N/A
Study type: Interventional

The purpose of this randomized, controlled, cross over single meal study is to investigate the metabolic effects of a breakfast rich in dairy proteins and to determine biomarkers for their intake. The results from this project will increase our knowledge about nutritional value of dairy proteins, which is necessary to decide whether dairy products can be recommended for prevention of weight related bone loss.

NCT ID: NCT01772615 Completed - Ulcerative Colitis Clinical Trials

Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissle

Start date: May 2011
Phase: Phase 4
Study type: Interventional

Purpose: The purpose of the study is to investigate if treatment with ciprofloxacin for one week followed by therapy with E. Coli Nissle (EcN) for seven weeks can influence disease activity among ulcerative colitis patients with disease flare-ups compared to placebo controls.

NCT ID: NCT01772576 Completed - Tachycardia Clinical Trials

Safety and Performance Study of the Reliance 4-Front Lead

Start date: October 2012
Phase: N/A
Study type: Interventional

The objective of this study is to gather data to establish the chronic safety, performance and effectiveness of the RELIANCE 4-FRONTâ„¢ Active Fixation Defibrillation Leads.

NCT ID: NCT01771601 Completed - Clinical trials for Near-infrared Spectroscopy, Transition, Caesarean Section

Cerebral Oximetry in Newborns - Comparing INVOS 5100c and OxyPrem vs. 1.2

Start date: January 2013
Phase: N/A
Study type: Observational

Regional tissue oxygenation (cStO2) can be monitored by near infrared spectroscopy. The commercial device INVOS 5100 (COVIDIEN, Mansfield, MA, USA) and the prototype OxyPrem vs. 1.2 (Biomedical Optics Research Laboratory, Zurich, Switzerland) will be used simultaneously to test for their relative sensitivity for low oxygen levels just after birth on term infants born by elective caesarean section. Reproducibility will be examined by replacements of the sensors six times the next day when the infant is stable and quiet. The Adult Somasensor (INVOS) will be used together with the OxyPrem sensor.

NCT ID: NCT01771315 Completed - Osteoarthritis Clinical Trials

Nurse Led Follow-up After Total Knee Arthroplasty

NFTKA
Start date: January 2013
Phase: N/A
Study type: Interventional

The aim of this study is to determine the effect of nurse led follow-up following total knee arthroplasty in regard to physical function, health related quality of life and self-efficacy.

NCT ID: NCT01771250 Completed - Clinical trials for Diabetes Mellitus, Type 1

A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 Diabetes

Start date: October 2013
Phase: Phase 1
Study type: Interventional

This study has two parts. Each participant will receive a daily injection of insulin peglispro during one treatment period and a daily injection of insulin glargine during the other treatment period. Each treatment period is 3 to 4 weeks and is followed by procedures to look at how the body uses or stores fats while taking each study drug.

NCT ID: NCT01770561 Completed - Diabetes Type 1 Clinical Trials

Feasibility Study of an Integrated Sensor and Infusion Set

Start date: October 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to collect performance data on the integrated sensor and infusion set during 3 days of use and demonstrate performance adequacy of the Integrated sensor and infusion set with glucose sensing and insulin delivery functionalities. The hypothesis of this study is that having the infusion of insulin in close proximity to the sensor does not interfere with the sensor accuracy.

NCT ID: NCT01769040 Completed - Liver Cirrhosis Clinical Trials

Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With Cirrhosis

Start date: November 2012
Phase: Phase 4
Study type: Interventional

This investigational trial will be assessing the effect of rifaximin on pathophysiology and haemodynamics in the patient with liver cirrhosis, and addressing the effect of rifaximin on several organs on marker level. The molecular and physiological effects of rifaximin will be explored. The investigators hypothesize that intestinal decontamination with rifaximin in patients with cirrhosis and ascites will interrupt bacterial translocation from the gut, diminish the following inflammatory response, prevent splanchnic vasodilatation and portal systemic contraction and thereby reduce the risk clinical complications to cirrhosis. If rifaximin can correct small intestinal bacterial overgrowth and demonstrate improvement in liver haemodynamics, renal function and systemic dynamics, then these effects may contribute to the overall well-being of the patient and prevent complications to the underlying cirrhosis such as risk of infections, progression of disease, and admission to hospital.

NCT ID: NCT01768143 Completed - Clinical trials for Competence in Propofol Sedation for Endoscopy

Assessment of NAPS Performance.

NAPSAT
Start date: January 2013
Phase: N/A
Study type: Observational

To measure competencies in propofol sedation for endoscopic procedures (NAPS)through development, test and validation of a reliable assessment tool in a simulator setting. Hypothesis: That the tool will demonstrate content and construct validity, ie. enable reliable measuring of necessary competencies of different levels in a reproducible way.

NCT ID: NCT01768130 Completed - Clinical trials for Persistent Pain After Open Inguinal Herniotomy

Variability in Thermal Thresholds in Patients With Persistent Pain After Open Inguinal Herniotomy

Start date: April 2011
Phase: N/A
Study type: Observational

The study will investigate the test-retest variability of thermal thresholds in patients with persistent pain after open inguinal herniotomy. Sensory mapping with a cool metal roller delineated an area with cool sensory dysfunction on the painful site. In this area and in a contralateral area as a control, 5 sites were outlined, including the point of maximum pain. In these total 10 sites warmth detection threshold (WDT), cool detection threshold (CDT) and heat pain threshold (HPT) were assessed using quantitative sensory testing. Tests were repeated after a 4-6 weeks interval.